Skip to main content

What the FDA labels say about taking them together

Asenapine and procainamide

Asenapine's FDA label of January 31, 2025 names procainamide in its warnings and precautions section; the procainamide label PlainMeds reads does not name asenapine.

Check it at the source: the asenapine FDA label on DailyMed (effective January 31, 2025, Allergan, Inc.); the procainamide FDA label on DailyMed (effective February 17, 2025, Caplin Steriles Limited).

What does the asenapine label say about procainamide?

Asenapine label, warnings and precautions

The use of SAPHRIS should be avoided in combination with other drugs known to prolong QTc including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), antipsychotic medications (e.g., ziprasidone, chlorpromazine, thioridazine), and antibiotics (e.g., gatifloxacin, moxifloxacin).

Source: FDA drug label (Secuado, NDA212268), Noven Therapeutics, LLC, effective January 30, 2025 (SPL set 685eaf44-5944-4f38-afba-0a4fc0b3462b), via openFDA

Source: FDA drug label (SAPHRIS), NDA022117 (Abbvie), as published by Allergan, Inc., effective January 31, 2025 (SPL set 5429f134-839f-4ffc-9944-55f51238def8), via openFDA; the full label on DailyMed

What does the procainamide label say about asenapine?

Procainamide's label (effective February 17, 2025) does not name asenapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Procainamide Hydrochloride), Caplin Steriles Limited, effective February 17, 2025 (SPL set fcaa5e9a-3c8a-4796-aa87-626268b6cf60), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Asenapine generic labelers
11Procainamide generic labelers
AsenapineProcainamide
Labeled forSchizophrenia, Bipolar disordern/a
Boxed warningYesYes
Pharmacy cost (NADAC)$2.63 per tablet 10 mg tablet sln/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?